Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 31265 matches for

The BTRU-PCT is sharing good practices for patient and public involvement in translational medicine

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

General Research

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.

Davis Group receives Wellcome Discovery Award

General MRC WIMM Research

Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.

RDM researcher receives award for research shedding light on microstructural and metabolic differences in hypertrophic cardiomyopathy patients

CVM General OCMR

Congratulations to Dr Zakariye Ashkir who received the Best Scientific Abstract Award from the Association of Inherited Cardiac Conditions at their Annual Conference held in Cambridge earlier this month.

BTRU Patient and Public Partners engaging with the NHS Blood and Transplant facility

BTRU co-lead is appointed as the Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation

RDM researchers at IF Oxford Science and Ideas Festival

General MRC WIMM OCDEM

Researchers from RDM’s Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) and the MRC Weatherall Institute of Molecular Medicine (WIMM) took centre stage at this year's IF Oxford Science and Ideas Festival with some exciting and interactive public engagement activities.

Peruvian interns gain invaluable research experience in RDM

CVM General OCMR

Two interns who have recently graduated from the Research Experience for Peruvian Undergraduates (REPU) have described how their experience of working alongside RDM researchers has opened doors to new opportunities.

Transformative treatments for children with fatal genetic lung diseases

General NDCLS Research

AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.

Launch of the new BHF Oxford Centre of Research Excellence

CVM General Research

Celebrating a £5million British Heart Foundation renewal award to the University of Oxford to advance cardiovascular science.

BTRU Patient Partners supporting training of the early career researchers

NIHR BTRU PCT

Evelyn Chakera and Julie Richardson-Abraham, BTRU Patient Partners, supported a training day for early career researchers - organised by the Advanced Therapy Academy.

Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population

DTU General OCDEM Publication Research

People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford’s Radcliffe Department of Medicine has found.

35 Years of the MRC WIMM

General MRC WIMM

In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.

New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs

CVM General OCDEM Research

Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.

Professor Robin Choudhury publishes a new book about the heart

CVM General Publication

Robin Choudhury, Professor of Cardiovascular Medicine, has written a book about the art and science of the heart. Here he answers some questions about the origins and highlights of the project.

Awards Success

NIHR BTRU PCT

Advanced Therapy Academy Training Day

NIHR BTRU PCT

The BTRU in Precision Cellular Therapeutics are proud to have hosted Advanced Therapy Academy Training Day on the 20 September 2024 at the Institute of Developmental & Regenerative Medicine, University of Oxford.

New biomarker and therapeutic target identified for blood cancers

General MRC MHU MRC WIMM

Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).

New Cross-Cutting Research Theme Lead for Advanced Therapy Medicinal Products

Department General NDCLS Research

Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients

General MRC MHU MRC WIMM Publication Research

In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.

Load More